United States Government Publishing Office publisher pbl distributor dst United States Congress Senate author aut Government Organization United States Congress House of Representatives author aut Government Organization text government publication eng BILLS An Act to amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing.;Improving Regulatory Transparency for New Medical Therapies Act;H.R. 639 (EAS) Bills and Statutes 114_cong_bills legislative 2015-10-26 U.S. Government Publishing Office 2015-10-26 monographic deposited born digital 14 p. Y 1.6: Y 1.4/6: P0b002ee18dcf1545 https://www.govinfo.gov/app/details/BILLS-114hr639eas H.R. 639 021-610-00252-9 000501532 000325573 Congressional bills House bills f:h639_eas.txt https://www.govinfo.gov/app/details/BILLS-114hr639eas https://www.govinfo.gov/content/pkg/BILLS-114hr639eas/html/BILLS-114hr639eas.htm https://www.govinfo.gov/content/pkg/BILLS-114hr639eas/pdf/BILLS-114hr639eas.pdf https://www.govinfo.gov/content/pkg/BILLS-114hr639eas/xml/BILLS-114hr639eas.xml fdlp DGPO 2015-10-26 2023-01-06 BILLS-114hr639eas machine generated eng Title 21 Section 355 Title 21 Section 360b Title 21 Section 360ccc-1 Title 21 Section 360ccc-2(c) Title 21 Section 360ccc(d) Title 21 Section 811 Title 21 Section 823 Title 21 Section 953 21 U.S.C. 355 21 U.S.C. 360b 21 U.S.C. 360ccc-1 21 U.S.C. 360ccc-2(c) 21 U.S.C. 360ccc(d) 21 U.S.C. 811 21 U.S.C. 823 21 U.S.C. 953 Title 42 Section 262 42 U.S.C. 262 hr BILLS-114hr639eas 114 1 HOUSE SENATE 639 eas eas Improving Regulatory Transparency for New Medical Therapies Act An Act to amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing. false false